RECURSION PHARMACEUTICALS, INC. Human Resources Contracts & Agreements
14 Contracts & Agreements
- Bonus & Incentive Agreements (3 contracts)
- Change of Control Agreements (2)
- Compensation Agreements (1)
- Employment Agreements (7)
- Transition Agreements (1)
- Employment Offer Letter, dated July 1, 2024, between the Registrant and Dr. Najat Khan, Ph.D (Filed With SEC on August 8, 2024)
- Transition Agreement between the Registrant and Shafique Virani (Filed With SEC on May 9, 2024)
- Employment Offer Letter, dated May 19, 2023, between the Registrant and Dr. David Mauro, M.D., Ph.D (Filed With SEC on August 8, 2023)
- 2021 Equity Incentive Plan and forms of agreements thereunder, to be in effect upon the completion of this offering (Filed With SEC on April 12, 2021)
- 2016 Equity Incentive Plan, as amended, and forms of agreement thereunder (Filed With SEC on April 12, 2021)
- CEO Executive Change in Control and Severance Plan (Filed With SEC on March 22, 2021)
- Executive Incentive Compensation Plan (Filed With SEC on March 22, 2021)
- Outside Director Compensation Policy (Filed With SEC on March 22, 2021)
- Executive Change in Control and Severance Plan (for executives other than the CEO) (Filed With SEC on March 22, 2021)
- Confirmatory Employment Letter between the Registrant and Shafique Virani (Filed With SEC on March 22, 2021)
- Confirmatory Employment Letter between the Registrant and Michael Secora (Filed With SEC on March 22, 2021)
- Confirmatory Employment Letter between the Registrant and Tina Marriott Larson (Filed With SEC on March 22, 2021)
- Confirmatory Employment Letter between the Registrant and Ramona Doyle (Filed With SEC on March 22, 2021)
- Confirmatory Employment Letter between the Registrant and Christopher Gibson, Ph.D (Filed With SEC on March 22, 2021)